ArticleNature communications2025

Post-resection delivery of a TLR7/8 agonist from a biodegradable scaffold achieves immune-mediated glioblastoma clearance and protection against tumor challenge in mice.

Elizabeth G Graham-Gurysh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.